Niğde State Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02752763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Niğde OHÜ

Active Ingredients

Drugs in Phase 4 Trials (1)

autologous serum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1